Sil1-deficient fibroblasts generate an aberrant extracellular matrix leading to tendon disorganisation in Marinesco-Sjögren syndrome.
Cell attachment
Cell motility
Collagen
Cytoskeleton
DQ-collagen
ER stress
Electron micrograph
Endoplasmic reticulum
Extracellular matrix
Skeletal muscle
Tendon
Transcriptomic analysis
Unfolded protein response
Woozy mouse
Wound-healing
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
23 Aug 2024
23 Aug 2024
Historique:
received:
29
05
2024
accepted:
05
08
2024
medline:
24
8
2024
pubmed:
24
8
2024
entrez:
23
8
2024
Statut:
epublish
Résumé
Marinesco-Sjögren syndrome (MSS) is an autosomal recessive neuromuscular disorder that arises in early childhood and is characterized by congenital cataracts, myopathy associated with muscle weakness, and degeneration of Purkinje neurons leading to ataxia. About 60% of MSS patients have loss-of-function mutations in the SIL1 gene. Sil1 is an endoplasmic reticulum (ER) protein required for the release of ADP from the master chaperone Bip, which in turn will release the folded proteins. The expression of non-functional Sil1 leads to the accumulation of unfolded proteins in the ER and this triggers the unfolded protein response (UPR). A dysfunctional UPR could be a key element in the pathogenesis of MSS, although our knowledge of the molecular pathology of MSS is still incomplete. RNA-Seq transcriptomics was analysed using the String database and the Ingenuity Pathway Analysis platform. Fluorescence confocal microscopy was used to study the remodelling of the extracellular matrix (ECM). Transmission electron microscopy (TEM) was used to reveal the morphology of the ECM in vitro and in mouse tendon. Our transcriptomic analysis, performed on patient-derived fibroblasts, revealed 664 differentially expressed (DE) transcripts. Enrichment analysis of DE genes confirmed that the patient fibroblasts have a membrane trafficking issue. Furthermore, this analysis indicated that the extracellular space/ECM and the cell adhesion machinery, which together account for around 300 transcripts, could be affected in MSS. Functional assays showed that patient fibroblasts have a reduced capacity of ECM remodelling, reduced motility, and slower spreading during adhesion to Petri dishes. TEM micrographs of negative-stained ECM samples from these fibroblasts show differences of filaments in terms of morphology and size. Finally, structural analysis of the myotendinous junction of the soleus muscle and surrounding regions of the Achilles tendon revealed a disorganization of collagen fibres in the mouse model of MSS (woozy). ECM alterations can affect the proper functioning of several organs, including those damaged in MSS such as the central nervous system, skeletal muscle, bone and lens. On this basis, we propose that aberrant ECM is a key pathological feature of MSS and may help explain most of its clinical manifestations.
Sections du résumé
BACKGROUND
BACKGROUND
Marinesco-Sjögren syndrome (MSS) is an autosomal recessive neuromuscular disorder that arises in early childhood and is characterized by congenital cataracts, myopathy associated with muscle weakness, and degeneration of Purkinje neurons leading to ataxia. About 60% of MSS patients have loss-of-function mutations in the SIL1 gene. Sil1 is an endoplasmic reticulum (ER) protein required for the release of ADP from the master chaperone Bip, which in turn will release the folded proteins. The expression of non-functional Sil1 leads to the accumulation of unfolded proteins in the ER and this triggers the unfolded protein response (UPR). A dysfunctional UPR could be a key element in the pathogenesis of MSS, although our knowledge of the molecular pathology of MSS is still incomplete.
METHODS
METHODS
RNA-Seq transcriptomics was analysed using the String database and the Ingenuity Pathway Analysis platform. Fluorescence confocal microscopy was used to study the remodelling of the extracellular matrix (ECM). Transmission electron microscopy (TEM) was used to reveal the morphology of the ECM in vitro and in mouse tendon.
RESULTS
RESULTS
Our transcriptomic analysis, performed on patient-derived fibroblasts, revealed 664 differentially expressed (DE) transcripts. Enrichment analysis of DE genes confirmed that the patient fibroblasts have a membrane trafficking issue. Furthermore, this analysis indicated that the extracellular space/ECM and the cell adhesion machinery, which together account for around 300 transcripts, could be affected in MSS. Functional assays showed that patient fibroblasts have a reduced capacity of ECM remodelling, reduced motility, and slower spreading during adhesion to Petri dishes. TEM micrographs of negative-stained ECM samples from these fibroblasts show differences of filaments in terms of morphology and size. Finally, structural analysis of the myotendinous junction of the soleus muscle and surrounding regions of the Achilles tendon revealed a disorganization of collagen fibres in the mouse model of MSS (woozy).
CONCLUSIONS
CONCLUSIONS
ECM alterations can affect the proper functioning of several organs, including those damaged in MSS such as the central nervous system, skeletal muscle, bone and lens. On this basis, we propose that aberrant ECM is a key pathological feature of MSS and may help explain most of its clinical manifestations.
Identifiants
pubmed: 39180052
doi: 10.1186/s12967-024-05582-0
pii: 10.1186/s12967-024-05582-0
doi:
Substances chimiques
SIL1 protein, human
0
Guanine Nucleotide Exchange Factors
0
SIL1 protein, mouse
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
787Subventions
Organisme : NextGenerationEU - MUR, Fondo Promozione e Sviluppo, DM 737/2021
ID : D75F21003210001
Organisme : Fondazione Telethon
ID : GGP20092
Organisme : Ministero dell'Università e della Ricerca
ID : DOT1353593-1
Informations de copyright
© 2024. The Author(s).
Références
Anttonen AK, Lehesjoki AE. Marinesco-Sjogren Syndrome. In GeneReviews(R). Edited by Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K. Seattle (WA); 2010.
Chiesa R, Sallese M. Review: protein misfolding diseases - the rare case of Marinesco-Sjogren syndrome. Neuropathol Appl Neurobiol. 2020;46:323–43.
pubmed: 31701543
doi: 10.1111/nan.12588
Ichhaporia VP, Hendershot LM. Role of the HSP70 Co-chaperone SIL1 in Health and Disease. Int J Mol Sci 2021, 22.
Krieger M, Roos A, Stendel C, Claeys KG, Sonmez FM, Baudis M, Bauer P, Bornemann A, de Goede C, Dufke A, et al. SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. Brain. 2013;136:3634–44.
pubmed: 24176978
doi: 10.1093/brain/awt283
Chung KT, Shen Y, Hendershot LM. BAP, a mammalian BiP-associated protein, is a nucleotide exchange factor that regulates the ATPase activity of BiP. J Biol Chem. 2002;277:47557–63.
pubmed: 12356756
doi: 10.1074/jbc.M208377200
Behnke J, Feige MJ, Hendershot LM. BiP and its nucleotide exchange factors Grp170 and Sil1: mechanisms of action and biological functions. J Mol Biol. 2015;427:1589–608.
pubmed: 25698114
pmcid: 4356644
doi: 10.1016/j.jmb.2015.02.011
Singh R, Kaur N, Choubey V, Dhingra N, Kaur T. Endoplasmic reticulum stress and its role in various neurodegenerative diseases. Brain Res. 2023;1826:148742.
pubmed: 38159591
doi: 10.1016/j.brainres.2023.148742
Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519–29.
pubmed: 17565364
doi: 10.1038/nrm2199
Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334:1081–6.
pubmed: 22116877
doi: 10.1126/science.1209038
Potenza F, Cufaro MC, Di Biase L, Panella V, Di Campli A, Ruggieri AG, Dufrusine B, Restelli E, Pietrangelo L, Protasi F et al. Proteomic analysis of Marinesco-Sjogren syndrome fibroblasts indicates pro-survival metabolic adaptation to SIL1 loss. Int J Mol Sci 2021, 22.
Ichhaporia VP, Kim J, Kavdia K, Vogel P, Horner L, Frase S, Hendershot LM. SIL1, the endoplasmic-reticulum-localized BiP co-chaperone, plays a crucial role in maintaining skeletal muscle proteostasis and physiology. Dis Model Mech 2018, 11.
Dzobo K, Dandara C. The Extracellular Matrix: its composition, function, remodeling, and role in Tumorigenesis. Biomimetics (Basel) 2023, 8.
Soles A, Selimovic A, Sbrocco K, Ghannoum F, Hamel K, Moncada EL, Gilliat S, Cvetanovic M. Extracellular Matrix Regulation in Physiology and in Brain Disease. Int J Mol Sci 2023, 24.
Long KR, Huttner WB. The role of the Extracellular Matrix in neural progenitor cell proliferation and cortical folding during Human Neocortex Development. Front Cell Neurosci. 2021;15:804649.
pubmed: 35140590
doi: 10.3389/fncel.2021.804649
Csapo R, Gumpenberger M, Wessner B. Skeletal muscle Extracellular Matrix - what do we know about its composition, regulation, and physiological roles? A narrative review. Front Physiol. 2020;11:253.
pubmed: 32265741
pmcid: 7096581
doi: 10.3389/fphys.2020.00253
Prein C, Beier F. ECM signaling in cartilage development and endochondral ossification. Curr Top Dev Biol. 2019;133:25–47.
pubmed: 30902255
doi: 10.1016/bs.ctdb.2018.11.003
Thomas K, Engler AJ, Meyer GA. Extracellular matrix regulation in the muscle satellite cell niche. Connect Tissue Res. 2015;56:1–8.
pubmed: 25047058
doi: 10.3109/03008207.2014.947369
Deries M, Goncalves AB, Vaz R, Martins GG, Rodrigues G, Thorsteinsdottir S. Extracellular matrix remodeling accompanies axial muscle development and morphogenesis in the mouse. Dev Dyn. 2012;241:350–64.
pubmed: 22127770
doi: 10.1002/dvdy.23703
Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev. 2004;84:649–98.
pubmed: 15044685
doi: 10.1152/physrev.00031.2003
Charvet B, Ruggiero F, Le Guellec D. The development of the myotendinous junction. A review. Muscles Ligaments Tendons J. 2012;2:53–63.
pubmed: 23738275
pmcid: 3666507
Filocamo M, Mazzotti R, Corsolini F, Stroppiano M, Stroppiana G, Grossi S, Lualdi S, Tappino B, Lanza F, Galotto S, Biancheri R. Cell line and DNA Biobank from patients affected by genetic diseases. Open J Bioresources. 2014;1:e2.
doi: 10.5334/ojb.ab
Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–90.
pubmed: 30423086
pmcid: 6129281
doi: 10.1093/bioinformatics/bty560
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
pubmed: 23104886
doi: 10.1093/bioinformatics/bts635
Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.
pubmed: 21816040
pmcid: 3163565
doi: 10.1186/1471-2105-12-323
McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288–97.
pubmed: 22287627
pmcid: 3378882
doi: 10.1093/nar/gks042
Quartararo JS, Eshelman MR, Peraro L, Yu H, Baleja JD, Lin YS, Kritzer JA. A bicyclic peptide scaffold promotes phosphotyrosine mimicry and cellular uptake. Bioorg Med Chem. 2014;22:6387–91.
pubmed: 25438762
pmcid: 4254597
doi: 10.1016/j.bmc.2014.09.050
Dufrusine B, Damiani V, Capone E, Pieragostino D, Dainese E, De Marco M, Reppucci F, Turco MC, Rosati A, Marzullo L, et al. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration. J Cell Biochem. 2022;123:65–76.
pubmed: 34741485
doi: 10.1002/jcb.30172
Petukhova VZ, Aboagye SY, Ardini M, Lullo RP, Fata F, Byrne ME, Gabriele F, Martin LM, Harding LNM, Gone V, et al. Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo. Nat Commun. 2023;14:3737.
pubmed: 37349300
pmcid: 10287695
doi: 10.1038/s41467-023-39444-y
Pietrangelo L, Michelucci A, Ambrogini P, Sartini S, Guarnier FA, Fusella A, Zamparo I, Mammucari C, Protasi F, Boncompagni S. Muscle activity prevents the uncoupling of mitochondria from ca(2+) release units induced by ageing and disuse. Arch Biochem Biophys. 2019;663:22–33.
pubmed: 30578752
doi: 10.1016/j.abb.2018.12.017
Pietrangelo L, D’Incecco A, Ainbinder A, Michelucci A, Kern H, Dirksen RT, Boncompagni S, Protasi F. Age-dependent uncoupling of mitochondria from Ca2(+) release units in skeletal muscle. Oncotarget. 2015;6:35358–71.
pubmed: 26485763
pmcid: 4742110
doi: 10.18632/oncotarget.6139
Kvist AJ, Johnson AE, Morgelin M, Gustafsson E, Bengtsson E, Lindblom K, Aszodi A, Fassler R, Sasaki T, Timpl R, Aspberg A. Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem. 2006;281:33127–39.
pubmed: 16956876
doi: 10.1074/jbc.M607892200
Ahmed IM, Lagopoulos M, McConnell P, Soames RW, Sefton GK. Blood supply of the Achilles tendon. J Orthop Res. 1998;16:591–6.
pubmed: 9820283
doi: 10.1002/jor.1100160511
Senderek J, Krieger M, Stendel C, Bergmann C, Moser M, Breitbach-Faller N, Rudnik-Schoneborn S, Blaschek A, Wolf NI, Harting I, et al. Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet. 2005;37:1312–4.
pubmed: 16282977
doi: 10.1038/ng1678
Anttonen AK, Mahjneh I, Hamalainen RH, Lagier-Tourenne C, Kopra O, Waris L, Anttonen M, Joensuu T, Kalimo H, Paetau A, et al. The gene disrupted in Marinesco-Sjogren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet. 2005;37:1309–11.
pubmed: 16282978
doi: 10.1038/ng1677
Ichhaporia VP, Sanford T, Howes J, Marion TN, Hendershot LM. Sil1, a nucleotide exchange factor for BiP, is not required for antibody assembly or secretion. Mol Biol Cell. 2015;26:420–9.
pubmed: 25473114
pmcid: 4310734
doi: 10.1091/mbc.E14-09-1392
Capone V, Clemente E, Restelli E, Di Campli A, Sperduti S, Ornaghi F, Pietrangelo L, Protasi F, Chiesa R, Sallese M. PERK inhibition attenuates the abnormalities of the secretory pathway and the increased apoptotic rate induced by SIL1 knockdown in HeLa cells. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3164–80.
pubmed: 30293566
doi: 10.1016/j.bbadis.2018.07.003
Roos A, Kollipara L, Buchkremer S, Labisch T, Brauers E, Gatz C, Lentz C, Gerardo-Nava J, Weis J, Zahedi RP. Cellular signature of SIL1 depletion: Disease Pathogenesis due to alterations in protein composition beyond the ER Machinery. Mol Neurobiol. 2016;53:5527–41.
pubmed: 26468156
doi: 10.1007/s12035-015-9456-z
Zhao L, Longo-Guess C, Harris BS, Lee JW, Ackerman SL. Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP. Nat Genet. 2005;37:974–9.
pubmed: 16116427
doi: 10.1038/ng1620
Lau LW, Cua R, Keough MB, Haylock-Jacobs S, Yong VW. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci. 2013;14:722–9.
pubmed: 23985834
doi: 10.1038/nrn3550
Levi N, Papismadov N, Solomonov I, Sagi I, Krizhanovsky V. The ECM path of senescence in aging: components and modifiers. FEBS J. 2020;287:2636–46.
pubmed: 32145148
doi: 10.1111/febs.15282
Pinter P, Alpar A. The role of Extracellular Matrix in Human Neurodegenerative diseases. Int J Mol Sci 2022, 23.
Opal P, Ashizawa T. Spinocerebellar Ataxia Type 1. In GeneReviews((R)). Edited by Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A. Seattle (WA); 1993.
Hamel K, Moncada EL, Sheeler C, Rosa J-G, Gilliat S, Zhang Y, Cvetanovic M. Loss of intracerebellar heterogeneity and selective vulnerability in spinocerebellar ataxia type 1 neurodegeneration. bioRxiv 2023:2022.2002.2024.481789.
Lamb CL, Cholico GN, Perkins DE, Fewkes MT, Oxford JT, Lujan TJ, Morrill EE, Mitchell KA. Aryl Hydrocarbon Receptor Activation by TCDD Modulates Expression of Extracellular Matrix Remodeling Genes during Experimental Liver Fibrosis. Biomed Res Int 2016, 2016:5309328.
Rahim T, Becquart P, Baeva ME, Quandt J. Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis. J Neuroinflammation. 2018;15:270.
pubmed: 30231889
pmcid: 6145183
doi: 10.1186/s12974-018-1290-6
Webb EA, AlMutair A, Kelberman D, Bacchelli C, Chanudet E, Lescai F, Andoniadou CL, Banyan A, Alsawaid A, Alrifai MT, et al. ARNT2 mutation causes hypopituitarism, post-natal microcephaly, visual and renal anomalies. Brain. 2013;136:3096–105.
pubmed: 24022475
pmcid: 3784281
doi: 10.1093/brain/awt218
Melouane A, Yoshioka M, St-Amand J. Extracellular matrix/mitochondria pathway: a novel potential target for Sarcopenia. Mitochondrion. 2020;50:63–70.
pubmed: 31669412
doi: 10.1016/j.mito.2019.10.007
Kwong AK, Zhang Y, Ho RS, Gao Y, Ling X, Tsang MH, Luk HM, Chung BH, Bonnemann CG, Javed A, Chan SH. Collagen VI-related myopathies: clinical variability, phenotype-genotype correlation and exploratory transcriptome study. Neuromuscul Disord. 2023;33:371–81.
pubmed: 37023487
doi: 10.1016/j.nmd.2023.03.003
Barraza-Flores P, Bates CR, Oliveira-Santos A, Burkin DJ. Laminin and integrin in LAMA2-Related congenital muscular dystrophy: from disease to therapeutics. Front Mol Neurosci. 2020;13:1.
pubmed: 32116540
pmcid: 7026472
doi: 10.3389/fnmol.2020.00001
Caria F, Cescon M, Gualandi F, Pichiecchio A, Rossi R, Rimessi P, Cotti Piccinelli S, Gallo Cassarino S, Gregorio I, Galvagni A, et al. Autosomal recessive Bethlem myopathy: a clinical, genetic and functional study. Neuromuscul Disord. 2019;29:657–63.
pubmed: 31471117
doi: 10.1016/j.nmd.2019.07.007
Wederell ED, de Iongh RU. Extracellular matrix and integrin signaling in lens development and cataract. Semin Cell Dev Biol. 2006;17:759–76.
pubmed: 17134921
doi: 10.1016/j.semcdb.2006.10.006
Edwards AO. Clinical features of the congenital vitreoretinopathies. Eye (Lond). 2008;22:1233–42.
pubmed: 18309337
doi: 10.1038/eye.2008.38
Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J Biol Chem. 2007;282:25668–76.
pubmed: 17567582
doi: 10.1074/jbc.M702076200
Dubail J, Cormier-Daire V. Chondrodysplasias with multiple dislocations caused by defects in Glycosaminoglycan Synthesis. Front Genet. 2021;12:642097.
pubmed: 34220933
pmcid: 8242584
doi: 10.3389/fgene.2021.642097
Gibson BG, Briggs MD. The aggrecanopathies; an evolving phenotypic spectrum of human genetic skeletal diseases. Orphanet J Rare Dis. 2016;11:86.
pubmed: 27353333
pmcid: 4924316
doi: 10.1186/s13023-016-0459-2
Cho SY, Bae JS, Kim NKD, Forzano F, Girisha KM, Baldo C, Faravelli F, Cho TJ, Kim D, Lee KY, et al. BGN mutations in X-Linked Spondyloepimetaphyseal Dysplasia. Am J Hum Genet. 2016;98:1243–8.
pubmed: 27236923
pmcid: 4908150
doi: 10.1016/j.ajhg.2016.04.004
Schinzel RT, Higuchi-Sanabria R, Shalem O, Moehle EA, Webster BM, Joe L, Bar-Ziv R, Frankino PA, Durieux J, Pender C, et al. The hyaluronidase, TMEM2, promotes ER Homeostasis and Longevity Independent of the UPR(ER). Cell. 2019;179:1306–e13181318.
pubmed: 31761535
pmcid: 6913896
doi: 10.1016/j.cell.2019.10.018
Chen X, Shi C, He M, Xiong S, Xia X. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct Target Ther. 2023;8:352.
pubmed: 37709773
pmcid: 10502142
doi: 10.1038/s41392-023-01570-w
Khoonkari M, Liang D, Lima MT, van der Land T, Liang Y, Sun J, Dolga A, Kamperman M, van Rijn P, Kruyt FAE. The unfolded protein response Sensor PERK mediates stiffness-dependent adaptation in Glioblastoma Cells. Int J Mol Sci 2022, 23.
Xiao Y, Xie X, Chen Z, Yin G, Kong W, Zhou J. Advances in the roles of ATF4 in osteoporosis. Biomed Pharmacother. 2023;169:115864.
pubmed: 37948991
doi: 10.1016/j.biopha.2023.115864